Article Details

GENERATION HD1 Trial Fails to Show Benefits of Tominersen

Retrieved on: 2021-05-06 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

GENERATION HD1 Trial Fails to Show Benefits of Tominersen. View article details on hiswai:

Excerpt

Roche, the company developing tominersen, decided to pause dosing in the clinical trial about a month ago, after a pre-planned review of trial data by ...

Article found on: huntingtonsdiseasenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up